Synthesis, characterization, and study of in vitro cytotoxicity of ZnO-Fe3O4 magnetic composite nanoparticles in human breast cancer cell line (MDA-MB-231) and mouse fibroblast … G Bisht, S Rayamajhi, B Kc, SN Paudel, D Karna, BG Shrestha Nanoscale research letters 11, 1-11, 2016 | 71 | 2016 |
Enhanced preferential cytotoxicity through surface modification: synthesis, characterization and comparative in vitro evaluation of TritonX-100 modified and unmodified zinc … B Kc, SN Paudel, S Rayamajhi, D Karna, S Adhikari, BG Shrestha, G Bisht Chemistry Central Journal 10, 1-10, 2016 | 62 | 2016 |
Immunotherapies for pediatric cancer: current landscape and future perspectives B Hutzen, SN Paudel, M Naeimi Kararoudi, KA Cassady, DA Lee, ... Cancer and Metastasis reviews 38 (4), 573-594, 2019 | 46 | 2019 |
The quest for effective immunotherapies against malignant peripheral nerve sheath tumors: Is there hope? SN Paudel, B Hutzen, TP Cripe Molecular Therapy-Oncolytics 30, 227-237, 2023 | 7 | 2023 |
Advancing Immunotherapy against Malignant Peripheral Nerve Sheath Tumors: Development of Myelolytic Viroimmunotherapy and Chlorotoxin Bispecific Engagers as a Therapeutic … SN Paudel The Ohio State University, 2023 | 1 | 2023 |
Using Gene Therapy to Solve Challenges with CAR-T Cell Immunotherapy: Lead Selection and Preclinical Development of an Adeno-Associated Virus with Reduced Immunogenicity … MA Currier, A Reha, B Hutzen, PY Wang, C Chen, A Glaspell, SN Paudel, ... Blood 144, 1056, 2024 | | 2024 |
Corrigendum: Myelomodulatory treatments augment the therapeutic benefit of oncolytic viroimmunotherapy in murine models of malignant peripheral nerve sheath tumors SN Paudel, BJ Hutzen, KE Miller, EAR Garfinkle, CY Chen, PY Wang, ... Frontiers in immunology 15, 1456897, 2024 | | 2024 |
Myelomodulatory treatments augment the therapeutic benefit of oncolytic viroimmunotherapy in murine models of malignant peripheral nerve sheath tumors SN Paudel, BJ Hutzen, KE Miller, EAR Garfinkle, CY Chen, PY Wang, ... Frontiers in immunology 15, 1384623, 2024 | | 2024 |